Sr. Dir. Regulatory Affairs, Head of Global Labeling and Labeling Operations

argenx US Inc; United States; Remoto; USD 268.000 - 369.000; Tempo pieno

Vantaggi offerti da questo lavoro

Health benefits

Retirement savings plans

Incentive programs

Descrizione del lavoro

argenx seeks a Senior Director, Head of Global Labeling and Labeling Operations to define and drive the global labeling strategy across development, registration, and post‑approval lifecycle. You will translate clinical data into FDA‑ready labeling, lead the Label Working Group, and partner across Regulatory, Safety, and Commercial teams.

Based in the United States, you will build and lead a high‑performing labeling organization, oversee external partners, and shape labeling governance to

Competenze

• 15+ years in biopharmaceutical regulatory affairs with labeling focus.
• Experience leading FDA labeling negotiations for NDAs/BLAs or major amendments.
• Proven ability translating efficacy and safety data into labeling positions.

Mansioni

• Define global labeling vision, priorities, and strategy across lifecycle.
• Lead FDA negotiations on labeling in partnership with US Regulatory Lead.
• Ensure labeling aligns with global regulatory strategy and lifecycle plans.
• Provide strategic recommendations on evidence requirements and risks.
• Build and mentor a high‑performing global labeling organization.

Conoscenze

Global labeling strategy

FDA negotiations

Regulatory leadership

Cross‑functional collaboration

Team leadership

Strategic reasoning

Lifecycle management

Executive communication

Formazione

Advanced scientific or clinical degree

Descrizione del lavoro

Join us as we transform immunology and deliver medicines that help autoimmune patients get their lives back. argenx is preparing for multi-dimensional expansion to reach more patients through a rich pipeline of differentiated assets, led by VYVGART, our first-in-class neonatal Fc receptor blocker approved for the treatment of gMG, and with the potential to treat patients across dozens of severe autoimmune diseases. We are building a new kind of biotech company, one that maintains its roots as a science-based start-up and pushes our commitment to innovate across all corners of our business. We strive to inspire and grow our company, our partnerships, our science, and our people, because when we do, we deliver more for patients.

argenx is looking for a Senior Director level Head of Global Labeling and Labeling Operations to lead and evolve its global labeling function in support of the continued development, registration, and successful commercialization of its existing and future marketed products.

Key Accountabilities and Responsibilities

This individual is a senior regulatory leader responsible for defining and executing global labeling strategy across the product lifecycle. The role serves as the company’s senior subject‑matter expert on labeling strategy, bringing deep experience translating clinical evidence into scientifically substantiated labeling proposals to inform labeling strategy and negotiations with global regulatory agencies, in particular the US Food and Drug Administration (FDA). The person in this role is a key member of the global regulatory leadership team and partners closely with Clinical Development, Technical Operations/Device, Safety, Medical Affairs, Commercial, Market Access, Legal, and regional Regulatory colleagues. This leader ensures labeling considerations inform development and evidence‑generation decisions, supports scientifically sound product differentiation, and maintains consistent, compliant labeling across markets. The role combines strategic leadership with hands‑on execution, including direct responsibility for selected high‑priority programs. This individual will lead and develop internal FTEs, manage consultants and external resources, and evolve the labeling function through the strategic implementation of a Target Product Label process and continued development of the internal Label Working Group and Global Labeling Committee.

The key responsibilities for this individual are:

• Define the global labeling vision, priorities, and strategy across development‑stage and marketed products.
• Serve as the senior regulatory authority for labeling strategy and lead preparation for and execution of FDA labeling negotiations, in partnership with the US Regulatory Lead.
• Ensure labeling strategies are integrated with global regulatory strategy, clinical development, safety evaluation, commercialization, and lifecycle planning.
• Provide senior leadership with clear recommendations on labeling opportunities, evidence requirements, regulatory risks, and negotiation trade‑offs.
• Build and develop a high‑performing global labeling organization, with accountability for internal FTEs, consultants, and external service providers.

Your primary areas of focus are:

• Global Labeling Strategy and Lifecycle Management – Lead the development and maintenance of Company Core Data Sheets (CCDS), US Prescribing Information (USPI), and EU product information, in partnership with regional Regulatory colleagues.
• Establish scientifically substantiated labeling positions for initial registrations, new indications, formulations/product presentations, patient populations, safety updates, and other lifecycle changes.
• Ensure proposed labeling is supported by the totality of available evidence, with clear identification of evidence gaps and potential regulatory challenges.
• Provide strategic oversight of regional and country labeling, ensuring alignment with core labeling while appropriately managing justified local differences.
• Partner with Safety to assess emerging information and ensure appropriate, timely updates to core and local labeling.
• Partner with the Head of US Advertising, Promotion and Strategic Commercialization to ensure a shared understanding of approved labeling, labeling limitations, and implications for compliant claims and communications.
• Lead labeling strategy throughout development, registration, and post‑approval lifecycle management.
• Provide strategic guidance on indication wording, patient populations, dosing, limitations of use, safety information, and presentation of clinical study results.
• Partner to develop labeling negotiation strategies, including objectives, evidence‑based arguments, alternative wording, fallback positions, and escalation pathways.
• Advise senior leadership on the clinical, patient, regulatory, and business implications of potential labeling outcomes.
• Monitor labeling precedents from key regions (eg US, EU, Japan), competitor labels, and evolving regulatory expectations, translating intelligence into actionable recommendations.
• Evolve the labeling function through the strategic implementation of a Target Product Label (TPL) process across development programs (early to late development) and relevant lifecycle opportunities.
• Evolve the TPL process to maximize ability to identify gaps between desired labeling and available or planned evidence, informing study design, endpoints, analyses, and development decisions.
• Evolve the internal Label Working Group into an effective forum for proactive labeling strategy, integrated scientific assessment, and timely decision‑making.
• Establish clear connections between TPL development, core labeling decisions, regional labeling proposals, and health‑authority negotiation positions.
• Drive evidence‑based resolution of differing views and accelerate material strategic issues to the appropriate governance body.
• Provide training and guidance to strengthen labeling capabilities and shared accountability across the organization.

Team Leadership, People Development and Functional Evolution

• Build, lead, and manage the global labeling team, with direct responsibility for internal FTEs and oversight of consultants and external service providers.
• Set clear objectives, responsibilities, and performance expectations; align resources with portfolio priorities and business needs.
• Mentor and coach team members through regular feedback, individual development planning, and opportunities to lead increasingly complex labeling activities.
• Develop scientific, strategic, negotiation, and leadership capabilities within the team; support career development and succession planning.
• Manage consultant scope, deliverables, quality, performance, and knowledge transfer to strengthen internal capabilities.
• Foster a collaborative, accountable environment in which team members constructively challenge assumptions and develop evidence‑based solutions.
• Evolve fit‑for‑purpose labeling processes, systems, standards, and interfaces with labeling operations, regional Regulatory, Safety, and packaging/artwork functions.
• Oversee functional capacity planning, budgets, vendor performance, labeling compliance, and inspection readiness.

Desired Skills and Experience

• Ideally, a minimum of 15 years of relevant biopharmaceutical industry experience, including substantial Regulatory Affairs experience and at least 7 years focused on labeling strategy.
• Advanced scientific or clinical degree preferred.
• Deep, hands‑on expertise in global labeling strategy across development, registration, and post‑approval lifecycle management.
• Demonstrated experience personally leading FDA labeling negotiations for original NDA/BLA approvals and/or major supplemental indications.
• Proven ability to interpret clinical efficacy and safety evidence and translate it into defensible labeling positions and successful negotiation strategies.
• Experience developing and maintaining TPLs, CCDS, USPI, and EU product information.
• Strong understanding of FDA labeling requirements and expectations, together with working knowledge of EU and other major‑market labeling requirements.
• Demonstrated experience implementing or evolving a TPL process and strengthening cross‑functional labeling governance.
• Proven leadership experience managing and developing internal FTEs, overseeing consultants, and operating effectively in a highly matrixed environment.
• Experience building or evolving a labeling function within a rapidly growing biopharmaceutical organization is desirable.
• Experience supporting product launches and major lifecycle milestones; biologics, specialty, or rare disease experience is a plus.
• Excellent executive communication, negotiation, presentation, and cross‑functional influencing skills.

You create a culture of collaboration, excellence, and innovation that inspires team members to perform at their highest abilities. You are a connector, building relationships and partnering across the organization to achieve company goals. You excel in a fast‑paced, results‑driven, highly accountable environment. You are pragmatic, yet creative and innovative, and lead while “rolling up your sleeves” to get it done. You show strong leadership through a proven ability to build, motivate, mentor, and develop a team. You resonate with the values of argenx and are ready to drive the company culture. You combine strategic thinking with the ability to execute, both individually and through teams, to achieve operational excellence in the face of challenging goals.

Candidates must be based in US (EST time zone), Belgium or Switzerland to be considered for this role.

For applicants in the United States: The annual base salary hiring range for this position is $268,000.00 - $368,500.00 USD. This range reflects our good faith estimate at the time of posting. Individual compensation is determined using objective, inclusive, and job‑related criteria such as relevant experience, skills, demonstrated competencies and internal equity. This means actual pay may differ from the posted range when justified by these factors. Because market conditions evolve, pay ranges are reviewed regularly and may be adjusted to remain aligned with external benchmarks. Note: If the posted hiring range does not apply to your work location, the recruiter will share the locally applicable annual base salary hiring range, provided in your country's currency, during the recruitment process. This information will reflect market conditions, role scope, and internal guidelines specific to your location. This job is eligible to participate in our short‑term and long‑term incentive programs, subject to the terms and conditions of those plans and applicable policies. It also includes a comprehensive benefits package, including but not limited to retirement savings plans, health benefits and other benefits subject to the terms of the applicable plans and program guidelines. At argenx, all applicants are welcomed in an inclusive environment. They will receive equal consideration for employment without discrimination on the basis of race, color, religion, sex, sexual orientation, gender identity, national origin, protected veteran status, disability, or any other applicable legally protected characteristics. argenx is proud to be an equal opportunity employer.

Before you submit your application, CV or any other personal details to us, please review our argenx Privacy Notice for Job Applicants to learn more about how argenx B.V. and its affiliates (“argenx”) will handle and protect your personal data. If you have any questions or you wish to exercise your privacy rights, please contact our Global Privacy Office by email at [e-mail].

If you require reasonable accommodation in completing your application, interviewing, or otherwise participating in the candidate selection process please contact us at [e-mail]. Only inquiries related to an accommodation request will receive a response.

argonauts work in locations around the globe including Belgium, Boston, Japan and Amsterdam. There's more to discover at argenx, where our passion inspires bold possibility. argenx honors the terms of our written agreements with the recruiting and staffing agencies that we retain and contract with to assist us with talent searches and other recruiting needs. Accordingly, all resumes and referrals that recruiting and staffing agencies proactively share with argenx that (i) were not solicited or requested by argenx’s internal Talent Acquisition team and (ii) were sent in the absence of a valid, written agreement between argenx and the firm, recruiter, or agency, may be pursued by argenx and are ineligible for payment of referral or other fees.